Aigen Investment Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $424K | Sell |
4,063
-2,671
| -40% | -$279K | 0.06% | 439 |
|
|
2025
Q1 | $785K | Buy |
6,734
+2,071
| +44% | +$242K | 0.13% | 251 |
|
|
2024
Q4 | $395K | Buy |
+4,663
| New | +$395K | 0.07% | 403 |
|
|
2024
Q1 | – | Sell |
-3,866
| Closed | -$308K | – | 672 |
|
|
2023
Q4 | $308K | Buy |
+3,866
| New | +$308K | 0.05% | 477 |
|
|
2023
Q1 | – | Sell |
-3,046
| Closed | -$235K | – | 617 |
|
|
2022
Q4 | $235K | Buy |
+3,046
| New | +$235K | 0.03% | 418 |
|